Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
14.89
+0.06 (0.40%)
At close: Oct 21, 2026, 4:00 PM EDT
15.09
+0.20 (1.34%)
Pre-market: Oct 22, 2026, 7:35 AM EDT
Cullinan Therapeutics Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Cullinan Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $33.45. The average 1-year stock price forecast is 124.65% higher than the current stock price, while the lowest is $23 (+54.47%) and the highest is $42 (+182.07%).
Price Target: $33.45 (+124.65%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cullinan Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 11 | 11 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Buy Reiterates $40 | Buy | Reiterates | $40 | +168.64% | Oct 20, 2026 |
| Wedbush | Wedbush | Buy Maintains $42 | Buy | Maintains | $42 | +182.07% | Oct 7, 2026 |
| Citi | Citi | Buy Maintains $33 | Buy | Maintains | $33 | +121.63% | Oct 7, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Oct 2, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $35 | Buy | Reiterates | $35 | +135.06% | Oct 2, 2026 |
Financial Forecast
Revenue This Year
13.88M
Revenue Next Year
52.79M
from 13.88M
Increased by 280.38%
EPS This Year
-3.13
from -3.36
EPS Next Year
-2.52
from -3.13
EPS and Forward PE are based on non-GAAP adjusted numbers.